| Application no. and date | 23164036.8 (espacenet) (Federated) (European Patent Register), 20150423 | | Patent/reg. no. and date | DK/EP 4219687, 20240814 | | Publication date | 20230802 | | Priority no. and date | US 201461983415 P, 20140423 | | EP pub. no. and date |
EP 4219687 20230802 | | Effective date | | | Applicant/owner | Juno Therapeutics, Inc., 400 Dexter Ave. N, Suite 1200
Seattle, WA 98109, US | | Applicant ref. no. | PU282311DKQ | | Inventor | CHAN, Calvin,
Seattle,WA 98109, US,
RAMSBORG, Chris,
Seattle, WA 98109, US,
BONYHADI, Mark, L,
Seattle, WA 98109, US,
BEAUCHESNE, Pascal,
Seattle, WA 98109, US | | Representative | Marks & Clerk LLP, 44, rue de la Vallée
L-2661 Luxembourg, LU | | Opponent | | | IPC Class | C12N 5/0781 (2010.01) , C12N 5/0783 (2010.01) | | Title | FREMGANGSMÅDER TIL ISOLERING, DYRKNING OG GENMANIPULERING AF IMMUNCELLEPOPULATIONER TIL ADOPTIV TERAPI | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
